CTI Biopharma Stock Price. Everything You Need To Know About The CTI Biopharma Stock!
CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. The company is headquartered in Seattle, Washington and currently employs 128 full-time employees. The firm is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). The company is also engaged in evaluating pacritinib for the treatment of adult patients with myelofibrosis. Its earlier stage product candidate, tosedostat, is an oral, once-daily aminopeptidase inhibitor that has demonstrated responses in patients with acute myeloid leukemia (AML). The company also evaluates its pipeline candidate paclitaxel poliglumex (Opaxio), which targets solid tumors. The company is evaluating Opaxio through cooperative group sponsored trials and investigator-sponsored trials (ISTs), such as the ongoing maintenance therapy trial in patients with ovarian cancer.
CTI Biopharma Stock Price. Everything You Need To Know About The CTI Biopharma Stock! performance -
Employees
128 -
Company HQ
Seattle -
Website
https://www.ctibiopharma.com/ -
Asset Type
-
Market Capitalization
0 - Earnings Per Share
- Dividends Per Share
- Dividend Date
- Quarterly Earnings Growth
Employees
128Company HQ
SeattleWebsite
https://www.ctibiopharma.com/Asset Type
Market Capitalization
0Looking to invest in CTI Biopharma from Malaysia, Thailand, Indonesia, or Vietnam? Look no further! CTI Biopharma is an innovative biopharmaceutical company focused on developing targeted therapies for blood-related cancers. With its cutting-edge research and development, CTI Biopharma is at the forefront of advancements in the field of oncology. Investing in CTI Biopharma can be a lucrative opportunity for retail investors from Malaysia, Thailand, Indonesia, and Vietnam. To get started, consider partnering with Zorion, a leading investment platform that provides investment insights and recommendations specifically tailored to your region. Zorion also offers a wide range of educational resources to enhance your investment knowledge and make informed decisions. Start investing in CTI Biopharma today and unlock your investment potential!
